Immune and inflammatory reactions in human allergic asthma has become a focus of intense interest over the past few years. The interaction of allergen with immune cells, in particular thymus derived lymphocytes (T cells) and antigen-presenting cells (APC) is critical to the development of allergy in humans. The development of this allergic inflammation is associated with the late phase of asthmatic responses, seen in human allergic asthma. The goals of the specific aims outlined in this proposal involve an in-depth examination of the specificity of the interaction between antigenic epitopes of allergens derived from rodent tissues, APC and specific immune T cells from individuals allergic to rodents. In the first specific aim we will examine the potential function of airway alveolar macrophages as APCs for allergen induced T cell activation in an Fc receptor dependent manner. We will assess the capacity of AM to function as APCs by a number of criteria. We will directly explore the capacity of Fc receptor bearing AM to support IL-1 production and augment APC dependent allergen presentation as evaluated by T cell proliferation and activation. The second specific aim involves the examination of the nature of recognition of allergenic epitopes by airway T cells in asthma. These experiments will examine in detail the nature and regulation of T cell recognition in the airways of asthmatics and normals. Whole population T cells, T cell lines and T cell clones from challenged airways will be evaluated for a) epitope specificity in terms of the nature of the antigenic determinant recognized by allergic and asthmatic T cells. We have previously identified a short 29 amino acid stretch of the overall 162 amino acid rodent allergen rat alpha 2 u globulin (RA2UG) that seems to be the target for most T cell reactivity. b) An evaluation of the V region gene usage for T cell receptors in whole population T cells, T cell lines, and T cell clones derived from challenged airways revealed by bronchoalveolar lavage. c) T cells will also be analyzed for cytokine expression after stimulation. In the final specific aim, the effect of in vivo immunotherapy with a fragment of the overall rodent allergen, peptide RA2UG 80-108 as well as whole allergen, Mus m 1, will be evaluated in an attempt to identify any potential benefit accrued to a course of immunotherapy with an epitope that seems to preferentially interact with the T cell compartment rather than with the B cell or IgE compartment. This immunotherapy trial will involve weekly injections of allergen administered over 4 months with evaluation in terms of breath units of Mus m 1 required to cause a 20% drop in FEV1 on three successive occasions prior to the immunotherapy trial and after the immunotherapy trial. This intervention and its immunologic manifestations should provide unusual insight into the mechanisms of immunotherapy and by implication, immune contributions to asthma.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL036577-08
Application #
3780564
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Takeda, Katsuyuki; Webb, Tracy L; Ning, Fangkun et al. (2018) Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation. J Immunol 200:1261-1269
Wang, Meiqin; Yang, Ivana V; Davidson, Elizabeth J et al. (2018) Forkhead box protein 3 demethylation is associated with tolerance induction in peanut-induced intestinal allergy. J Allergy Clin Immunol 141:659-670.e2
Gelfand, Erwin W; Joetham, Anthony; Wang, Meiqin et al. (2017) Spectrum of T-lymphocyte activities regulating allergic lung inflammation. Immunol Rev 278:63-86
Gelfand, Erwin W (2017) Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma. Semin Immunol 33:44-51
Goleva, Elena; Covar, Ronina; Martin, Richard J et al. (2016) Corticosteroid pharmacokinetic abnormalities in overweight and obese corticosteroid resistant asthmatics. J Allergy Clin Immunol Pract 4:357-60.e2
Takeda, Katsuyuki; Miyahara, Nobuaki; Matsubara, Shigeki et al. (2016) Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw 16:165-75
Schedel, Michaela; Jia, Yi; Michel, Sven et al. (2016) 1,25D3 prevents CD8(+)Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat Commun 7:10213
Wang, M; Han, J; Domenico, J et al. (2016) Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function. Allergy 71:1561-1574
Medda, Rituparna; Lyros, Orestis; Schmidt, Jamie L et al. (2015) Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells. Microvasc Res 97:167-80
Li, Ling-Bo; Leung, Donald Y M; Goleva, Elena (2015) Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics. PLoS One 10:e0141909

Showing the most recent 10 out of 471 publications